๊ฑฐ๋ž˜์†Œ
์ค‘์•™ํ™” ๊ฑฐ๋ž˜์†Œ
ํƒˆ์ค‘์•™ํ™” ๊ฑฐ๋ž˜์†Œ

Moderna Inc ์ฃผ๊ฐ€
MRNA
#532

โ‚ฉ90,125.74
ย ย 

5.11%

Moderna Inc Info

์‹œ๊ฐ€์ด์•ก
โ‚ฉ35.98T

5.11%

์ผ๊ฐ„ ๊ฑฐ๋ž˜๋Ÿ‰
โ‚ฉ451.15B
์›น์‚ฌ์ดํŠธ
์ž์‚ฐ ์œ ํ˜•
์ฃผ์‹
์ง์›
5800
์„ค๋ฆฝ
Sep 1, 2010
์ฃผ ๊ฑฐ๋ž˜์†Œ
Nasdaq
์‚ฐ์—…
Biological Products, (No Diagnostic Substances)
CIK ๋ฒˆํ˜ธ
0001682852

ํ† ํฐํ™”๋œ ์ฃผ์‹ ๋ฐ์ดํ„ฐ

ํ‰๊ท  ํ† ํฐํ™”๋œ ๊ฐ€๊ฒฉ
โ‚ฉ89.91K
๊ฐ€๊ฒฉ ์ฐจ์ด
+โ‚ฉ208.85(-0.23%)
ํ† ํฐํ™”๋œ ์‹œ์ด
โ‚ฉ75.58M

5.95%

ํ† ํฐํ™”๋œ ๊ฑฐ๋ž˜๋Ÿ‰(24์‹œ๊ฐ„)
โ‚ฉ2.9M

49.42%

๋ฐœํ–‰์ธ
๊ณ„์•ฝ
์ต์Šคํ”Œ๋กœ๋Ÿฌ
MRNA USD ๋ณ€ํ™˜๊ธฐ
MRNA
KRW
๊ฐ€๊ฒฉ ํผํฌ๋จผ์Šค
๋‚ฎ์Œ
โ‚ฉ90.12K
๋†’์Œ
โ‚ฉ90.12K

๋ฐ์ดํ„ฐ ๋กœ๋”ฉ ์ค‘

์ž ์‹œ๋งŒ ๊ธฐ๋‹ค๋ ค ์ฃผ์„ธ์š”, ์ฐจํŠธ ๋ฐ์ดํ„ฐ๋ฅผ ๋กœ๋”ฉํ•˜๊ณ  ์žˆ์Šต๋‹ˆ๋‹ค

Moderna Inc ์ปค๋ฎค๋‹ˆํ‹ฐ

skeleton-white
ย 
ย 
ย 
ย 
ย 
ย 

Moderna Inc ์†Œ๊ฐœ

What is Moderna Inc?

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

Moderna Inc ๋ผ์ด๋ธŒ ๊ฐ€๊ฒฉ ๋ฐ์ดํ„ฐ

Moderna Inc์˜ ํ˜„์žฌ ์‹œ์žฅ ๊ฐ€๊ฒฉ์€ โ‚ฉ90,125.74์ด๋ฉฐ 24์‹œ๊ฐ„ ๊ฑฐ๋ž˜๋Ÿ‰์€ โ‚ฉ451.15B์ž…๋‹ˆ๋‹ค. ํ•ด๋‹น ์ž์‚ฐ์˜ ์‹œ๊ฐ€์ด์•ก์€ ์ง€๋‚œ 24์‹œ๊ฐ„ ๋™์•ˆ 5.12% ๋ณ€๋™ํ•œ ํ›„ โ‚ฉ35.98T์ž…๋‹ˆ๋‹ค.

ํ† ํฐํ™”๋œ Moderna Inc์€(๋Š”) โ‚ฉ89,916.88์— ๊ฑฐ๋ž˜๋˜๊ณ  ์žˆ์œผ๋ฉฐ, ํ† ํฐํ™”๋œ ์‹œ๊ฐ€์ด์•ก์€ โ‚ฉ75.58M, 24์‹œ๊ฐ„ ๊ฑฐ๋ž˜๋Ÿ‰์€ โ‚ฉ2.9M์ž…๋‹ˆ๋‹ค. ํ•ด๋‹น ํ† ํฐํ™”๋œ ์ž์‚ฐ์€ ์ง€๋‚œ 24์‹œ๊ฐ„ ๋™์•ˆ 5.95% ๋ณ€๋™ํ–ˆ์Šต๋‹ˆ๋‹ค.